CPT® Code 84681

The CPT® Code 84681 refers to the laboratory test for measuring C-peptide levels in the blood or urine. C-peptide is a byproduct of insulin production, and its measurement is crucial for assessing the functionality of pancreatic beta cells, which are responsible for insulin secretion. This test is particularly significant in the context of diabetes management, as it helps to monitor insulin production and can aid in diagnosing the underlying causes of low blood glucose levels. The C-peptide test may be ordered for patients who have recently been diagnosed with diabetes or metabolic syndrome to evaluate their residual beta cell function. Additionally, it is useful in the detection and monitoring of insulinomas, which are tumors that arise in the islet cells of the pancreas and can lead to excessive insulin production. Elevated C-peptide levels may indicate conditions such as endogenous insulin production, insulinomas, hypokalemia, pregnancy, Cushing syndrome, and renal failure. Conversely, low C-peptide levels may suggest diminished beta cell function, which can be a critical factor in the management of diabetes. The test is performed by obtaining a blood sample through venipuncture, which is a separately reportable procedure, or by collecting a 24-hour urine sample. The analysis of serum and urine samples is conducted using a quantitative chemiluminescent immunoassay, a sensitive and specific method for measuring C-peptide concentrations.